NASDAQ Composite opens in less than two hours and FibroGen‘s pre-market value is already 5.52% down.

The last session, NASDAQ Composite finished with FibroGen (FGEN) rising 2.47% to $21.56. NASDAQ Composite jumped 2.32% to $13,429.98, after two sequential sessions in a row of gains, on what was an all-around positive trend trading session.

FibroGen’s last close was $21.04, 165.35% below its 52-week high of $57.21.

The company’s growth estimates for the current quarter and the next is 2.2% and 51.6%, respectively.

FibroGen’s Revenue

Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.

FibroGen’s Stock Yearly Top and Bottom Value

FibroGen’s stock is valued at $21.56 at 08:11 EST, way under its 52-week high of $57.21 and above its 52-week low of $20.29.

FibroGen’s Moving Average

FibroGen’s worth is way below its 50-day moving average of $39.14 and way under its 200-day moving average of $42.31.


FibroGen’s last day, last week, and last month’s current volatility was 0.43%, 3.05%, and 2.60%, respectively.

FibroGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.76% (day), 7.54% (last week), and 5.74% (last month), respectively.

More news about FibroGen (FGEN).


Please enter your comment!
Please enter your name here